- Home
- ZYXI vs VNDA Comparison
ZYXI vs VNDA Comparison
Compare ZYXI & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZYXI
- VNDA
- Stock Information
- Founded
- ZYXI 1996
- VNDA 2002
- Country
- ZYXI United States
- VNDA United States
- Employees
- ZYXI N/A
- VNDA N/A
- Industry
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- VNDA Biotechnology: Pharmaceutical Preparations
- Sector
- ZYXI Health Care
- VNDA Health Care
- Exchange
- ZYXI Nasdaq
- VNDA Nasdaq
- Market Cap
- ZYXI 257.1M
- VNDA 270.2M
- IPO Year
- ZYXI N/A
- VNDA 2006
- Fundamental
- Price
- ZYXI $9.01
- VNDA $5.19
- Analyst Decision
- ZYXI Strong Buy
- VNDA Strong Buy
- Analyst Count
- ZYXI 2
- VNDA 2
- Target Price
- ZYXI $14.00
- VNDA $15.50
- AVG Volume (30 Days)
- ZYXI 117.3K
- VNDA 787.4K
- Earning Date
- ZYXI 10-24-2024
- VNDA 11-06-2024
- Dividend Yield
- ZYXI N/A
- VNDA N/A
- EPS Growth
- ZYXI N/A
- VNDA N/A
- EPS
- ZYXI 0.15
- VNDA N/A
- Revenue
- ZYXI $193,665,000.00
- VNDA $190,858,000.00
- Revenue This Year
- ZYXI $10.70
- VNDA $6.70
- Revenue Next Year
- ZYXI $19.78
- VNDA $51.03
- P/E Ratio
- ZYXI $61.07
- VNDA N/A
- Revenue Growth
- ZYXI 4.21
- VNDA N/A
- 52 Week Low
- ZYXI $7.15
- VNDA $3.30
- 52 Week High
- ZYXI $13.77
- VNDA $6.75
- Technical
- Relative Strength Index (RSI)
- ZYXI 54.55
- VNDA 64.14
- Support Level
- ZYXI $7.97
- VNDA $4.56
- Resistance Level
- ZYXI $9.30
- VNDA $5.30
- Average True Range (ATR)
- ZYXI 0.39
- VNDA 0.18
- MACD
- ZYXI 0.01
- VNDA 0.06
- Stochastic Oscillator
- ZYXI 55.17
- VNDA 86.75
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS), Fanapt for the treatment of schizophrenia and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from HETLIOZ product sales.